RxDoctor Payments Data

Erica Dorondo

Medical · Ford City, PANPI 1154661452

Payments from drug & device makers

$4,184in general payments, 2019–2025

Across 266 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$999
  • AbbVie$512
  • Lilly USA, LLC$372
  • Takeda Pharmaceuticals U.S.A., Inc.$305
  • GSK$225
  • Boehringer Ingelheim$182
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$4,184100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,184 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$42,051
Medicare patients
174
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$62,662
EliquisApixaban67$54,842
XareltoRivaroxaban85$48,365
RybelsusSemaglutide33$36,544
JardianceEmpagliflozin36$26,893
Humulin R U-500 KwikpenInsulin Regular, Human15$26,703
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$20,357
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$12,807
Tresiba Flextouch U-100Insulin Degludec13$6,248
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,220
Atorvastatin Calcium306$4,169
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,502
Levothyroxine Sodium286$3,134
Pantoprazole Sodium287$3,099
Potassium Chloride103$2,515

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$999$99,20692 claims
PfizerEliquis$107$54,84267 claims
Johnson & JohnsonXarelto$64$48,36585 claims
Boehringer IngelheimJardiance$182$26,89336 claims
GSKTrelegy Ellipta, Anoro Ellipta$225$26,57735 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$3,134286 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Ford City

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →